Scholarly Index
Thomas Quertermous
Cardiovascular Institute of the South; 61,975 total citations; 514 total publications; best world rank #25
Cardiovascular Institute of the South
61,975Total citations
514Total publications
109H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Apelin-related biomedical research | Lifetime | 25 | US 9 | 98.50 |
| Congenital heart defects research | Lifetime | 282 | US 157 | 97.82 |
| Angiogenesis and VEGF in Cancer | Lifetime | 382 | US 176 | 97.63 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 112 | US 24 | 97.08 |
| Nuclear Receptors and Signaling | Lifetime | 217 | US 101 | 96.74 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 538 | US 208 | 96.66 |
| Lipid metabolism and disorders | Lifetime | 309 | US 120 | 96.57 |
| Protease and Inhibitor Mechanisms | Lifetime | 656 | US 275 | 96.36 |
| Genetic Associations and Epidemiology | Lifetime | 774 | US 388 | 96.30 |
| Single-cell and spatial transcriptomics | Lifetime | 649 | US 330 | 93.54 |
| Congenital heart defects research | 2021-2025 | 110 | US 53 | 91.05 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 206 | US 45 | 90.76 |
| Single-cell and spatial transcriptomics | 2021-2025 | 656 | US 293 | 88.74 |